Acute, moderate Pain

Also known as:Moderate Acute pain

Drug	Drug Name	Drug Description
DB08976	Floctafenine	An anti-inflammatory analgesic used to manage mild to moderate acute pain.
DB00465	Ketorolac	An NSAID used to treat moderate to severe pain, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, menstrual disorders, and headaches.
DB00497	Oxycodone	An opioid used in the management of moderate to severe pain.
DB06204	Tapentadol	An opioid used to manage severe pain that has not responded to non-opioid medications, and for which opioid analgesic therapy is appropriate.

Drug	Drug Name	Target	Type
DB00465	Ketorolac	Prostaglandin G/H synthase 1	target
DB00465	Ketorolac	Prostaglandin G/H synthase 2	target
DB00465	Ketorolac	UDP-glucuronosyltransferase 2B7	enzyme
DB00465	Ketorolac	Cytochrome P450 2C8	enzyme
DB00465	Ketorolac	Cytochrome P450 2C9	enzyme
DB00497	Oxycodone	Mu-type opioid receptor	target
DB00497	Oxycodone	Kappa-type opioid receptor	target
DB00497	Oxycodone	Delta-type opioid receptor	target
DB00497	Oxycodone	Cytochrome P450 2D6	enzyme
DB00497	Oxycodone	Cytochrome P450 3A4	enzyme
DB00497	Oxycodone	Cytochrome P450 3A5	enzyme
DB00497	Oxycodone	Serum albumin	carrier
DB00497	Oxycodone	alpha1-acid glycoprotein	carrier
DB06204	Tapentadol	Mu-type opioid receptor	target
DB06204	Tapentadol	Kappa-type opioid receptor	target
DB06204	Tapentadol	Delta-type opioid receptor	target
DB06204	Tapentadol	Sodium-dependent noradrenaline transporter	target
DB06204	Tapentadol	5-hydroxytryptamine receptor 3A	target
DB06204	Tapentadol	UDP-glucuronosyltransferase 1-9	enzyme
DB06204	Tapentadol	UDP-glucuronosyltransferase 2B7	enzyme
DB06204	Tapentadol	Cytochrome P450 2D6	enzyme
DB06204	Tapentadol	Cytochrome P450 2C9	enzyme
DB06204	Tapentadol	Cytochrome P450 2C19	enzyme
DB06204	Tapentadol	Sodium-dependent serotonin transporter	target

Drug	Drug Name	Phase	Status	Count